Development and Validation of a Prognostic Risk Model for Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors.
Igor StukalinVishal NavaniMehul GuptaYibing RuanDevon J BoyneDylan E O'SullivanDaniel E MeyersSiddhartha GoutamMichael SanderBenjamin W EwanchukDarren R BrennerAleksi SuoWinson Y CheungDaniel Y C HengJose G MonzonTina ChengPublished in: The oncologist (2023)
Liver metastases, low albumin, high LDH, high WBC, and ECOG≥1 can be combined into a prognostic model for AM patients treated with ICI.
Keyphrases